Levamisole is a potent enhancer of gilthead seabream natural cytotoxic activity

Vet Immunol Immunopathol. 2002 Oct 28;89(3-4):169-74. doi: 10.1016/s0165-2427(02)00220-9.

Abstract

Gilthead seabream (Sparus aurata L.) head-kidney (HK) leucocytes were incubated with 10(3) to 10(-4) ng levamisole/ml for 4, 24 or 48 h and then assayed for their natural cytotoxic activity against xenogeneic tumor cells. This activity was slightly increased after 24 h of incubation. In a second experiment, fish specimens were fed 0, 75, 150 or 300 mg levamisole/kg diet for 10 consecutive days. The fish were then fed a commercial non-supplemented diet and sampled 0, 1, 2, 3, 4 and 6 weeks post-administration of levamisole. The cytotoxic activity was found increased along the experiment and remained greatly enhanced at the end. In conclusion, levamisole enhanced seabream natural cytotoxic cell activity both in vitro and in vivo and had a great and lasting action when administered by feeding.

MeSH terms

  • Adjuvants, Immunologic* / administration & dosage
  • Adjuvants, Immunologic* / pharmacology
  • Animal Feed
  • Animals
  • Cytotoxicity, Immunologic / drug effects
  • Cytotoxicity, Immunologic / immunology*
  • Diet
  • Fish Diseases / immunology
  • Fish Diseases / prevention & control
  • Immunity, Innate / immunology*
  • Leukocytes / immunology*
  • Levamisole / administration & dosage
  • Levamisole / immunology*
  • Levamisole / pharmacology
  • Logistic Models
  • Sea Bream / immunology*
  • Time Factors
  • Tumor Cells, Cultured

Substances

  • Adjuvants, Immunologic
  • Levamisole